Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.

Liraglutide restores impaired associative learning in individuals with obesity

Open access

Abstract

Survival under selective pressure is driven by the ability of our brain to use sensory information to our advantage to control physiological needs. To that end, neural circuits receive and integrate external environmental cues and internal metabolic signals to form learned sensory associations, consequently motivating and adapting our behaviour. The dopaminergic midbrain plays a crucial role in learning adaptive behaviour and is particularly sensitive to peripheral metabolic signals, including intestinal peptides, such as glucagon-like peptide 1 (GLP-1). In a single-blinded, randomized, controlled, crossover basic human functional magnetic resonance imaging study relying on a computational model of the adaptive learning process underlying behavioural responses, we show that adaptive learning is reduced when metabolic sensing is impaired in obesity, as indexed by reduced insulin sensitivity (participants: N = 30 with normal insulin sensitivity; N = 24 with impaired insulin sensitivity). Treatment with the GLP-1 receptor agonist liraglutide normalizes impaired learning of sensory associations in men and women with obesity. Collectively, our findings reveal that GLP-1 receptor activation modulates associative learning in people with obesity via its central effects within the mesoaccumbens pathway. These findings provide evidence for how metabolic signals can act as neuromodulators to adapt our behaviour to our body’s internal state and how GLP-1 receptor agonists work in clinics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s42255-023-00859-y

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Experimental design. a, Randomization of participants. In this interventional crossover study, all participants underwent a placebo and a liraglutide session. The order of the interventions was counterbalanced across participants. b, Outline of the testing day; BMI, body mass index; VAS, visual analogue scale used for hunger rating; SL task, associative sensory learning task assessing trial-wise learning processes.
Fig. 1 Experimental design. a, Randomization of participants. In this interventional crossover study, all participants underwent a placebo and a liraglutide session. The order of the interventions was counterbalanced across participants. b, Outline of the testing day; BMI, body mass index; VAS, visual analogue scale used for hunger rating; SL task, associative sensory learning task assessing trial-wise learning processes.CC BY · PubMed Central
Fig. 2 Differential effect of liraglutide on trial-wise measures of learning. a–c, While leaving sensory prediction errors (a) unchanged, liraglutide normalizes the adaptive learning rate (b) and adaptive prediction error (c) in individuals with impaired insulin sensitivity to the level of insulin-sensitive individuals. Data are presented as mean ± s.e.m. Data were analysed by mixed effect models with post hoc tests using Tukey’s procedure to test for the effects of intervention (placebo versus liraglutide) and group (IS+ versus IS–) on the respective learning parameter (IS+: placebo n = 17, liraglutide n = 18; IS–: placebo n = 17, liraglutide n = 16); *P < 0.05; ***P < 0.001; NS, not significant. Original P values are provided in Supplementary Table 1a–f. Source data
Fig. 2 Differential effect of liraglutide on trial-wise measures of learning. a–c, While leaving sensory prediction errors (a) unchanged, liraglutide normalizes the adaptive learning rate (b) and adaptive prediction error (c) in individuals with impaired insulin sensitivity to the level of insulin-sensitive individuals. Data are presented as mean ± s.e.m. Data were analysed by mixed effect models with post hoc tests using Tukey’s procedure to test for the effects of intervention (placebo versus liraglutide) and group (IS+ versus IS–) on the respective learning parameter (IS+: placebo n = 17, liraglutide n = 18; IS–: placebo n = 17, liraglutide n = 16); *P < 0.05; ***P < 0.001; NS, not significant. Original P values are provided in Supplementary Table 1a–f. Source dataCC BY · PubMed Central
Fig. 3 Liraglutide enhances learning-related brain activity in individuals with impaired insulin sensitivity. The interaction group × intervention identified brain regions in which the encoding of adaptive prediction errors was more strongly enhanced by liraglutide than placebo in the insulin-resistant group (IS–) than in the insulin-sensitive group (IS+). Liraglutide enhanced adaptive prediction error encoding in the IS– group in the SCA and the ventral striatum (vStr). Activation maps were overlayed on the standard brain atlas provided by the Montreal Neurological Institute (MNI) (the statistical threshold was P < 0.05, with data family-wise error corrected at the cluster level and with an underlying voxel-level threshold of P < 0.001). Statistical analyses were conducted using Statistical Parametric Mapping version 12 in the framework of a general linear model (GLM) with flexible factorial designs. Bars and error bars correspond to the mean and s.e.m. of the contrast estimates at the peak of the cluster inferred at the group level, reflecting the relationship between trial-wise BOLD responses to visual outcomes and adaptive prediction errors. The corresponding activation peaks are marked with white crosses, with respective anatomical labels and MNI coordinates (x, y and z) indicated in each plot. Data points correspond to the individual contrast estimates at the same voxel (IS+: placebo n = 17, liraglutide n = 18; IS–: placebo n = 17, liraglutide n = 16); **P < 0.01. Source data
Fig. 3 Liraglutide enhances learning-related brain activity in individuals with impaired insulin sensitivity. The interaction group × intervention identified brain regions in which the encoding of adaptive prediction errors was more strongly enhanced by liraglutide than placebo in the insulin-resistant group (IS–) than in the insulin-sensitive group (IS+). Liraglutide enhanced adaptive prediction error encoding in the IS– group in the SCA and the ventral striatum (vStr). Activation maps were overlayed on the standard brain atlas provided by the Montreal Neurological Institute (MNI) (the statistical threshold was P < 0.05, with data family-wise error corrected at the cluster level and with an underlying voxel-level threshold of P < 0.001). Statistical analyses were conducted using Statistical Parametric Mapping version 12 in the framework of a general linear model (GLM) with flexible factorial designs. Bars and error bars correspond to the mean and s.e.m. of the contrast estimates at the peak of the cluster inferred at the group level, reflecting the relationship between trial-wise BOLD responses to visual outcomes and adaptive prediction errors. The corresponding activation peaks are marked with white crosses, with respective anatomical labels and MNI coordinates (x, y and z) indicated in each plot. Data points correspond to the individual contrast estimates at the same voxel (IS+: placebo n = 17, liraglutide n = 18; IS–: placebo n = 17, liraglutide n = 16); **P < 0.01. Source dataCC BY · PubMed Central
Extended Data Fig. 1 Correlation between BMI and HOMA-IR. Within the study participants, BMI and HOMA-IR were highly correlated; r2 = 0.26, P < 0.001 based on the Pearson’s correlation test. Source data
Extended Data Fig. 1 Correlation between BMI and HOMA-IR. Within the study participants, BMI and HOMA-IR were highly correlated; r2 = 0.26, P < 0.001 based on the Pearson’s correlation test. Source dataCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 98 references

Cited by

See all 52

Metadata

Authors
Hanssen, R., Rigoux, L., Kuzmanovic, B., Iglesias, S., Kretschmer, A. C., Schlamann, M., Albus, K., Edwin Thanarajah, S., Sitnikow, T., Melzer, C., Cornely, O. A., Brüning, J. C., & Tittgemeyer, M.
Affiliations
  • University of Cologne (DE)
  • Max Planck Institute for Metabolism Research (DE)
  • University of Zurich (CH)
Corresponding author
Tittgemeyer, Marc
Venue
Nature Metabolism
Published
2023-08-17
Volume
5
Issue
8
Pages
1352-1363
ISSN
2522-5812 (ISSN-L)
OpenAlex
W4385955544
Cited by
52
References
98
Citations by year
2026: 12 · 2025: 26 · 2024: 11 · 2023: 3
FWCI
7.73
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Metabolism (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
  • Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
  • ETH Zürich Research Collection (cc-by)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • University College London
  • Deutsche Forschungsgemeinschaft (SFB 1451, 390661388, 431549029)
  • Eidgenössische Technische Hochschule Zürich
  • Max-Planck-Gesellschaft
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
liraglutide, obesity, associative learning, glucagon-like peptide-1, GLP-1 receptor agonists, insulin resistance, dopaminergic midbrain, metabolic sensing, neuromodulation, computational models of learning, sensory associations
MeSH terms
Glucagon-Like Peptide-1 Receptor, Liraglutide, Female, Humans, Insulin Resistance, Male, Obesity, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Liraglutide restores impaired associative learning in individuals with obesity. https://app.cochat.ai/papers/10.1038/s42255-023-00859-y
The paper
Hanssen, R., Rigoux, L., Kuzmanovic, B., Iglesias, S., Kretschmer, A. C., Schlamann, M., Albus, K., Edwin Thanarajah, S., Sitnikow, T., Melzer, C., Cornely, O. A., Brüning, J. C., & Tittgemeyer, M. (2023). Liraglutide restores impaired associative learning in individuals with obesity. Nature Metabolism. https://doi.org/10.1038/s42255-023-00859-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.